Clinical Trial Update: Analysis of Tissues From Patients in Trial of Myo-Inositol to Prevent Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial analysis of tissues from patients treated with myo-inositol to prevent lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Myo-inositol (myo-inositol)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AKT | Phase 1 | Status: COMPLETED